Bausch Health Cos Asset Turnover 2010-2023 | BHC

Bausch Health Cos asset turnover from 2010 to 2023. Asset turnover can be defined as the amount of sales or revenues generated per dollar of assets. The asset turnover ratio is an indicator of the efficiency with which a company is deploying its assets.
Bausch Health Cos Asset Turnover Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.858B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.673B 5.66
Dr Reddy's Laboratories (RDY) India $12.551B 19.84
Aspen Pharmacare (APNHY) South Africa $5.574B 0.00
BridgeBio Pharma (BBIO) United States $5.208B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.042B 14.20
Supernus Pharmaceuticals (SUPN) United States $1.695B 0.00
Taysha Gene Therapies (TSHA) United States $0.481B 0.00
Generation Bio (GBIO) United States $0.211B 0.00
Personalis (PSNL) United States $0.078B 0.00
Assembly Biosciences (ASMB) United States $0.072B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00